OLEMA PHARMACEUTICALS

Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

20 сен 2023 06:29:20 Источник Nasdaq GlobeNewswire

Olema Oncology to Participate in Upcoming Investor Conferences

06 сен 2023 15:30:55 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 сен 2023 15:30:00 Источник Nasdaq GlobeNewswire

Olema Oncology Announces Combined Financing for Up to $180 Million

05 сен 2023 06:30:49 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 авг 2023 15:03:07 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 авг 2023 15:30:34 Источник Nasdaq GlobeNewswire

Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference

01 авг 2023 07:00:10 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 июл 2023 06:30:32 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 июн 2023 15:30:23 Источник Nasdaq GlobeNewswire

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

30 май 2023 15:30:43 Источник Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

11 май 2023 07:43:20 Источник Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

09 май 2023 15:01:03 Источник Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

08 май 2023 06:06:10 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 май 2023 15:30:57 Источник Nasdaq GlobeNewswire

Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

13 апр 2023 15:30:48 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 апр 2023 15:30:50 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update

09 мар 2023 15:00:17 Источник Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 мар 2023 16:00:11 Источник Nasdaq GlobeNewswire

Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference

02 мар 2023 15:05:19 Источник Nasdaq GlobeNewswire

Olema Oncology to Participate at Upcoming Investor Conferences

21 фев 2023 15:30:35 Источник Nasdaq GlobeNewswire